The individual research projects that make up this Ovarian Cancer SPORE application require theprocurement, processing, and analysis of histopathological material from patients with ovarian cancer andbenign ovarian diseases. The research projects have needs for frozen and formalin-fixed, paraffinembeddedsamples of tumor and normal tissue. The Pathology Core augments the already establishedM.D. Anderson Cancer Center Gynecological Tumor Bank and the P30-sponsored M.D. Anderson CancerCenter Centralized Tissue Repository with supporting database and intranet access. The Core providestissue acquisition by experienced gynecological pathologists to assure high-quality tissues for theinvestigators participating in this SPORE as well as investigators of other SPOREs.The goal of the Pathology Core is to provide frozen tissue, paraffin-embedded tissue, and histopathologicalexpertise related to the specific needs for the research projects comprising this SPORE proposal. Toachieve this goal, the Pathology Core has the following Specific Aims.
Aim 1 is to maintain a frozen andparaffin-embedded tissue repository of ovarian cancer, benign ovarian processes, and normal ovary. Theprimary tissue source is operative and biopsy specimens submitted to the Department of Pathology at M.D.Anderson Cancer Center. In addition, a subcontract with Duke University provides additional ovariantissues, particularly early stage ovarian cancers.
Aim 2 is to provide pathological review for all clinicalspecimens utilized in the SPORE projects and to provide histopathological technical services as necessary.Such technical services include immunohistochemistry, in situ hybridization, creation of specific tissuemicroarray slides, and microdissection of tissue sections.
Aim 3 is to establish a blood/urine/ascites fluidrepository from patients undergoing surgery for ovarian cancer and benign ovarian processes. These fluidsprovide the resources for the systemic testing of putative prognostic and diagnostic markers derived fromtissue-based expression array and CGH experiments.
Aim 4 is to create and maintain a SPORE Databasefor all samples collected at both M.D. Anderson Cancer Center and Duke University. This SPORE Databaseis a virtual tissue repository that is electronically shared by all SPORE investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA083639-09
Application #
7729379
Study Section
Special Emphasis Panel (ZCA1-GRB-I (O1))
Project Start
2008-09-04
Project End
2010-08-31
Budget Start
2008-09-04
Budget End
2009-08-31
Support Year
9
Fiscal Year
2008
Total Cost
$144,481
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Seo, Hyeonglim; Choi, Ikjang; Whiting, Nicholas et al. (2018) Hyperpolarized Porous Silicon Nanoparticles: Potential Theragnostic Material for 29 Si Magnetic Resonance Imaging. Chemphyschem 19:2143-2147
Mitamura, T; Pradeep, S; McGuire, M et al. (2018) Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP). Oncogene 37:722-731
Yuan, Jiao; Hu, Zhongyi; Mahal, Brandon A et al. (2018) Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers. Cancer Cell 34:549-560.e9
Liu, Xiaojun; Jiang, Yingjun; Nowak, Billie et al. (2018) Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations. Cancer Chemother Pharmacol 81:255-267
Haemmerle, Monika; Stone, Rebecca L; Menter, David G et al. (2018) The Platelet Lifeline to Cancer: Challenges and Opportunities. Cancer Cell 33:965-983
Allen, Julie K; Armaiz-Pena, Guillermo N; Nagaraja, Archana S et al. (2018) Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction. Cancer Res 78:3233-3242
Umamaheswaran, Sujanitha; Dasari, Santosh K; Yang, Peiying et al. (2018) Stress, inflammation, and eicosanoids: an emerging perspective. Cancer Metastasis Rev 37:203-211
Wang, Jue; Zhao, Wei; Guo, Huifang et al. (2018) AKT isoform-specific expression and activation across cancer lineages. BMC Cancer 18:742
Huang, Yan; Hu, Wei; Huang, Jie et al. (2018) Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer. Mol Cancer Ther 17:464-473
Yang, Hailing; Mao, Weiqun; Rodriguez-Aguayo, Cristian et al. (2018) Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability. Clin Cancer Res 24:5072-5084

Showing the most recent 10 out of 648 publications